Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation

The constant presence of the viral genome in Epstein-Barr virus (EBV)-associated gastric cancers (EBVaGCs) suggests the applicability of novel EBV-targeted therapies. The antiviral nucleoside drug, ganciclovir (GCV), is effective only in the context of the viral lytic cycle in the presence of EBV-en...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun Gyu, Kim, Hyemi, Kim, Eun Jung, Park, Pil-Gu, Dong, Seung Myung, Choi, Tae Hyun, Kim, Hyunki, Chong, Curtis R., Liu, Jun O., Chen, Jianmeng, Ambinder, Richard F., Hayward, S. Diane, Park, Jeon Han, Lee, Jae Myun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741585/
https://www.ncbi.nlm.nih.gov/pubmed/26427042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741585/
https://www.ncbi.nlm.nih.gov/pubmed/26427042

Ejemplares similares